• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

A public health call to arms: The long build to FDA’s misinformation guidance

cafead

Administrator
Staff member
  • cafead   Jul 25, 2024 at 10:02: PM
via In the first part of a three-part series, MM+M examines the factors underlying the need for regulatory guidance on combating the proliferation of online health misinformation.

article source